van der Vliet, D., Vesikari, T., Sandner, B., Martinón-Torres, F., Muzsay, G., Forsten, A., . . . Dhingra, M. S. (2021). Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: A phase III randomised study. Epidemiol Infect.
Citação norma Chicagovan der Vliet, D., et al. "Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-conjugate Vaccine (MenACYW-TT) Vs. a Licensed Quadrivalent Meningococcal Tetanus Toxoid-conjugate Vaccine in Meningococcal Vaccine-naïve and Meningococcal C Conjugate Vaccine-primed Toddlers: A Phase III Randomised Study." Epidemiol Infect 2021.
MLA Citationvan der Vliet, D., et al. "Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-conjugate Vaccine (MenACYW-TT) Vs. a Licensed Quadrivalent Meningococcal Tetanus Toxoid-conjugate Vaccine in Meningococcal Vaccine-naïve and Meningococcal C Conjugate Vaccine-primed Toddlers: A Phase III Randomised Study." Epidemiol Infect 2021.